<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04632875</url>
  </required_header>
  <id_info>
    <org_study_id>2010-180-2</org_study_id>
    <nct_id>NCT04632875</nct_id>
  </id_info>
  <brief_title>Online Trial of Meditation and Behavior</brief_title>
  <official_title>Identifying Neural Correlates of Altruism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates how different types of meditation may affect behaviors and emotions.&#xD;
      The study is conducted entirely online and involves listening to 4-weeks of a guided&#xD;
      meditation training. The meditation involves either Loving-Kindness or Relaxation techniques.&#xD;
      The purpose of the study is to assess changes in behaviors and emotions using standard&#xD;
      questionnaires, reports of real-world behavior, and online behavioral tasks. The overarching&#xD;
      goal is to help clarify how mind-body practices may improve some aspects of well-being.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 4, 2020</start_date>
  <completion_date type="Actual">June 10, 2021</completion_date>
  <primary_completion_date type="Actual">June 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Social functioning</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Participants will complete a questionnaire about their real-world social behaviors. An aggregate score will be computed; higher scores will indicate better social functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Affective responses</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Participants will perform a wall-sit test and responses will be measured using a 0-100 Visual Analog Scale of intensity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychological well-being related to COVID-19</measure>
    <time_frame>4-5 weeks</time_frame>
    <description>Participants will complete a questionnaire related to the psychological impact of COVID-19 social distancing. Higher scores will indicate worse psychological impact of COVID-19.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Meditation</condition>
  <arm_group>
    <arm_group_label>Loving-Kindness Meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4-week guided Loving-Kindness Meditation training (administered online).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Relaxation Meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4-week guided Relaxation Meditation training (administered online).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Loving-Kindness Meditation</intervention_name>
    <description>Approximately 15-minute sessions are administered 6 days per week</description>
    <arm_group_label>Loving-Kindness Meditation</arm_group_label>
    <other_name>Metta Meditation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Relaxation Meditation</intervention_name>
    <description>Approximately 15-minute sessions are administered 6 days per week</description>
    <arm_group_label>Relaxation Meditation</arm_group_label>
    <other_name>Progressive Muscle Relaxation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Is a medically healthy individual&#xD;
&#xD;
          -  Lives in the United States&#xD;
&#xD;
          -  Has reliable internet access and the ability to join a Zoom video chat&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Has experience with meditation or other mind-body practices&#xD;
&#xD;
          -  Has a neurological disease&#xD;
&#xD;
          -  Has a current psychiatric disorder&#xD;
&#xD;
          -  Is on medication that affects the central nervous system (e.g. psychotropic drugs)&#xD;
&#xD;
          -  Has recurrent or chronic pain&#xD;
&#xD;
          -  Is pregnant or planning to become pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abigail A Marsh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georgetown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Georgetown University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 10, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>June 11, 2021</last_update_submitted>
  <last_update_submitted_qc>June 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

